Literature DB >> 15465191

Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.

Yvette Seppenwoolde1, Katrien De Jaeger, Liesbeth J Boersma, José S A Belderbos, Joos V Lebesque.   

Abstract

PURPOSE: To study regional differences in lung radiosensitivity by evaluating the incidence of radiation pneumonitis (RP) in relation to regional dose distributions. METHODS AND MATERIALS: Registered chest CT and single photon emission CT lung perfusion scans were obtained in 106 patients before curative or radical radiotherapy for non-small-cell lung cancer. The mean lung dose (MLD) was calculated. The single photon-emission CT perfusion data were used to weigh the MLD with perfusion, resulting in the mean perfusion-weighted lung dose. In addition, the lungs were geometrically divided into different subvolumes. The mean regional dose (MRD) for each region was calculated and weighted with the perfusion of each region to obtain the mean perfusion-weighted regional dose. RP was defined as respiratory symptoms requiring steroids. The incidence of RP for patients with tumors in a specific subvolume was calculated. The normal tissue complication probability (NTCP) parameter values for the TD(50), and an offset NTCP parameter for tumor location were fitted for both lungs and for each lung subvolume to the observed data using maximum likelihood analysis.
RESULTS: The incidence of RP correlated significantly with the MLD and MRD of the posterior, caudal, ipsilateral, central, and peripheral lung subvolumes (p between 0.05 and 0.002); no correlation was seen for the anterior, cranial, and contralateral regions Similarly, a statistically significant correlation was observed between the incidence of RP and the perfusion-weighted MLD and perfusion-weighted MRD for all regions, except the anterior lung region. For this region, the dose-effect relation improved remarkably after weighting the local dose with the local perfusion. A statistically significant difference (p = 0.01) in the incidence of RP was found between patients with cranial and caudal tumors (11% and 40%, respectively). Therefore, a dose-independent offset NTCP parameter for caudal tumors was included in the NTCP model, improving most correlations significantly, confirming that patients with caudal tumors have a greater probability of developing RP.
CONCLUSION: The incidence of RP correlated significantly with the MLD and MRD of most lung regions, except for the anterior, cranial, and contralateral regions. Weighting the local dose with the local perfusion improved the dose-effect relation for the anterior lung region. Irradiation of caudally located lung tumors resulted in a greater risk of RP than irradiation of tumors located in other parts of the lungs.

Entities:  

Mesh:

Year:  2004        PMID: 15465191     DOI: 10.1016/j.ijrobp.2004.04.037

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  47 in total

Review 1.  Imaging for assessment of radiation-induced normal tissue effects.

Authors:  Robert Jeraj; Yue Cao; Randall K Ten Haken; Carol Hahn; Lawrence Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 2.  Radiation dose-volume effects in the lung.

Authors:  Lawrence B Marks; Soren M Bentzen; Joseph O Deasy; Feng-Ming Spring Kong; Jeffrey D Bradley; Ivan S Vogelius; Issam El Naqa; Jessica L Hubbs; Joos V Lebesque; Robert D Timmerman; Mary K Martel; Andrew Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

3.  Heart irradiation as a risk factor for radiation pneumonitis.

Authors:  Ellen X Huang; Andrew J Hope; Patricia E Lindsay; Marco Trovo; Issam El Naqa; Joseph O Deasy; Jeffrey D Bradley
Journal:  Acta Oncol       Date:  2010-09-28       Impact factor: 4.089

4.  Functional-guided radiotherapy using knowledge-based planning.

Authors:  Austin M Faught; Lindsey Olsen; Leah Schubert; Chad Rusthoven; Edward Castillo; Richard Castillo; Jingjing Zhang; Thomas Guerrero; Moyed Miften; Yevgeniy Vinogradskiy
Journal:  Radiother Oncol       Date:  2018-04-05       Impact factor: 6.280

5.  Correlation between pneumonitis risk in radiation oncology and lung density measured with X-ray computed tomography.

Authors:  Abdulhamid Chaikh; Jacques Balosso
Journal:  Quant Imaging Med Surg       Date:  2016-08

6.  Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy.

Authors:  Dongqing Wang; Baosheng Li; Zhongtang Wang; Jian Zhu; Hongfu Sun; Jian Zhang; Yong Yin
Journal:  Exp Ther Med       Date:  2011-06-29       Impact factor: 2.447

Review 7.  Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.

Authors:  Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

8.  Combining multiple models to generate consensus: application to radiation-induced pneumonitis prediction.

Authors:  Shiva K Das; Shifeng Chen; Joseph O Deasy; Sumin Zhou; Fang-Fang Yin; Lawrence B Marks
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

9.  Patients with severe emphysema have a low risk of radiation pneumonitis following stereotactic body radiotherapy.

Authors:  M Ishijima; H Nakayama; T Itonaga; Y Tajima; S Shiraishi; M Okubo; R Mikami; K Tokuuye
Journal:  Br J Radiol       Date:  2014-12-09       Impact factor: 3.039

10.  Use of 4-dimensional computed tomography-based ventilation imaging to correlate lung dose and function with clinical outcomes.

Authors:  Yevgeniy Vinogradskiy; Richard Castillo; Edward Castillo; Susan L Tucker; Zhongxing Liao; Thomas Guerrero; Mary K Martel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-03-06       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.